CNTA logo

Centessa Pharmaceuticals (CNTA) CAPEX

annual CAPEX:

N/A
December 31, 2024

Summary

  • CNTA annual capital expenditures is not available.

Performance

1-year change

-

3-year change

-

5-year change

-

15-year change

-

CNTA CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

All-time high

$169.00K
CNTA annual capital expenditures is currently at an all-time high

3-year low

$169.00K
CNTA annual capital expenditures is currently at its 3-year low

Earnings dates

Last annual earnings report date

Dec 31, 2024
CNTA previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
CNTA next annual earnings announcement has not yet been scheduled

OtherCNTAcash flow metrics

annual FCF

-$142.09M
CNTA annual free cash flow is -$142.09 million

annual CFO

-$142.06M
CNTA annual cash flow from operations is -$142.06 million

annual CFI

$31.27M
CNTA annual cash flow from investing activities is $31.27 million

annual CFF

$364.75M
CNTA annual cash flow from financing activities is $364.75 million

quarterly CAPEX:

N/A
March 31, 2025

Summary

  • CNTA quarterly capital expenditures is not available.

Performance

3-month change

-

1-year change

-

3-year change

-

5-year change

-

CNTA quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

All-time high

$34.00K
CNTA quarterly capital expenditures is currently at an all-time high

3-year low

$0.00
CNTA quarterly capital expenditures is currently at its 3-year low

Earnings dates

Last quarterly earnings report date

Mar 31, 2025
CNTA previous earnings announcement was published on Mar 31, 2025

Next quarterly earnings report date

Aug 13, 2025
CNTA next earnings announcement is scheduled for Aug 13, 2025

OtherCNTAcash flow metrics

quarterly FCF

-$57.25M
CNTA quarterly free cash flow is -$57.25 million

quarterly CFO

-$57.25M
CNTA quarterly cash flow from operations is -$57.25 million

quarterly CFI

-$222.39M
CNTA quarterly cash flow from investing activities is -$222.39 million

quarterly CFF

$3.09M
CNTA quarterly cash flow from financing activities is $3.09 million

TTM CAPEX:

N/A
March 31, 2025

Summary

  • CNTA TTM capital expenditures is not available.

Performance

3-month change

-

1-year change

-

3-year change

-

5-year change

-

CNTA TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

All-time high

$62.00K
CNTA TTM capital expenditures is currently at an all-time high

3-year low

$28.00K
CNTA TTM capital expenditures is currently at its 3-year low

Earnings dates

Last quarterly earnings report date

Mar 31, 2025
CNTA previous earnings announcement was published on Mar 31, 2025

Next quarterly earnings report date

Aug 13, 2025
CNTA next earnings announcement is scheduled for Aug 13, 2025

OtherCNTAcash flow metrics

TTM FCF

-$162.05M
CNTA TTM free cash flow is -$162.05 million

TTM CFO

-$162.01M
CNTA TTM cash flow from operations is -$162.01 million

TTM CFI

-$207.88M
CNTA TTM cash flow from investing activities is -$207.88 million

TTM CFF

$357.35M
CNTA TTM cash flow from financing activities is $357.35 million

CNTA CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years---
5 y5 years---

CNTA CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year
5 y5-year
alltimeall time

CNTA CAPEX History

DateAnnualQuarterlyTTM
Dec 2024
-
$0.00(-100.0%)
$34.00K(-45.2%)
DateAnnualQuarterlyTTM
Sep 2024
-
$34.00K(+21.4%)
$62.00K(+121.4%)
Dec 2023
$169.00K
$28.00K
$28.00K

FAQ

  • What is the all time high annual CAPEX for Centessa Pharmaceuticals?
  • What is the all time high quarterly CAPEX for Centessa Pharmaceuticals?
  • What is the all time high TTM CAPEX for Centessa Pharmaceuticals?

What is the all time high annual CAPEX for Centessa Pharmaceuticals?

Centessa Pharmaceuticals all-time high annual capital expenditures is $169.00K

What is the all time high quarterly CAPEX for Centessa Pharmaceuticals?

Centessa Pharmaceuticals all-time high quarterly capital expenditures is $34.00K

What is the all time high TTM CAPEX for Centessa Pharmaceuticals?

Centessa Pharmaceuticals all-time high TTM capital expenditures is $62.00K
On this page